A detailed history of Credential Qtrade Securities Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Credential Qtrade Securities Inc. holds 27,972 shares of AZN stock, worth $2.03 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
27,972
Previous 26,802 4.37%
Holding current value
$2.03 Million
Previous $1.81 Billion 4.99%
% of portfolio
0.1%
Previous 0.11%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 21, 2025

BUY
$61.03 - $69.57 $71,405 - $81,396
1,170 Added 4.37%
27,972 $1.9 Billion
Q4 2023

Jul 21, 2025

SELL
$61.89 - $69.28 $161,409 - $180,682
-2,608 Reduced 8.87%
26,802 $1.81 Billion
Q3 2023

Jul 21, 2025

SELL
$64.85 - $71.7 $34,111 - $37,714
-526 Reduced 1.76%
29,410 $1.99 Billion
Q2 2023

Jul 21, 2025

SELL
$69.91 - $75.81 $39,289 - $42,605
-562 Reduced 1.84%
29,936 $2.14 Billion
Q1 2023

Jul 21, 2025

BUY
$63.15 - $71.6 $23,618 - $26,778
374 Added 1.24%
30,498 $2.12 Billion
Q4 2022

Jul 21, 2025

BUY
$54.21 - $70.44 $49,547 - $64,382
914 Added 3.13%
30,124 $2.04 Billion
Q3 2022

Jul 21, 2025

BUY
$53.02 - $135.75 $93,050 - $238,241
1,755 Added 6.39%
29,210 $1.6 Billion
Q2 2022

Jul 21, 2025

BUY
$59.26 - $71.14 $88,652 - $106,425
1,496 Added 5.76%
27,455 $1.81 Billion
Q1 2022

Jul 21, 2025

SELL
$55.72 - $67.12 $807,438 - $972,635
-14,491 Reduced 35.82%
25,959 $1.72 Billion
Q4 2021

Jul 21, 2025

BUY
$54.02 - $63.83 $124,029 - $146,553
2,296 Added 6.02%
40,450 $2.36 Billion
Q3 2021

Jul 21, 2025

BUY
$55.56 - $60.79 $93,118 - $101,884
1,676 Added 4.59%
38,154 $2.29 Billion
Q2 2021

Jul 21, 2025

BUY
$48.42 - $60.18 $206,366 - $256,487
4,262 Added 13.23%
36,478 $2.19 Billion
Q1 2021

Jul 21, 2025

BUY
$47.16 - $54.44 $406,283 - $469,000
8,615 Added 36.5%
32,216 $1.6 Billion
Q4 2020

Jul 21, 2025

SELL
$48.52 - $58.02 $5,240 - $6,266
-108 Reduced 0.46%
23,601 $1.18 Billion
Q3 2020

Jul 21, 2025

SELL
$53.07 - $61.1 $31,152 - $35,865
-587 Reduced 2.42%
23,709 $1.3 Billion
Q2 2020

Jul 21, 2025

BUY
$43.1 - $55.31 $25,558 - $32,798
593 Added 2.5%
24,296 $1.29 Billion
Q1 2020

Jul 21, 2025

BUY
$37.79 - $51.33 $464,476 - $630,897
12,291 Added 107.7%
23,703 $1.06 Billion
Q4 2019

Jul 21, 2025

BUY
$42.46 - $50.46 $3,991 - $4,743
94 Added 0.83%
11,412 $569 Million
Q3 2019

Jul 21, 2025

BUY
$40.12 - $45.47 $17,452 - $19,779
435 Added 4.0%
11,318 $504 Million
Q2 2019

Jul 21, 2025

BUY
$37.28 - $41.68 $7,940 - $8,877
213 Added 2.0%
10,883 $449 Million
Q1 2019

Jul 21, 2025

SELL
$35.49 - $43.02 $402,030 - $487,330
-11,328 Reduced 51.5%
10,670 $431 Million
Q4 2018

Jul 21, 2025

BUY
$36.86 - $41.49 $1,511 - $1,701
41 Added 0.19%
21,998 $835 Million
Q3 2018

Jul 21, 2025

BUY
$34.76 - $39.72 $763,225 - $872,132
21,957 New
21,957 $869 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $225B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Credential Qtrade Securities Inc. Portfolio

Follow Credential Qtrade Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Credential Qtrade Securities Inc. with notifications on news.